Pet Therapeutic Diet Market Report Scope & Overview:
The pet therapeutic diet market was valued at USD 4.20 billion in 2024 and is expected to reach USD 7.47 billion by 2032, growing at a CAGR of 7.48% over the forecast period of 2025-2032.
The global pet therapeutic diet market is driven by increasing inclination of pet owners toward pet preventive care and management of chronic diseases. As owners increasingly regard pets as family members, they spend on specialty diets designed for conditions including obesity and kidney disease. Educational efforts, veterinary advice, and access to telemedicine are behind this trend. The pet therapeutic diet market trends indicate an increasing demand for personalized nutrition, which is projected to be a consequence of elevated standards of pet care, preventive health management, and adoption of technology-driven veterinary care.
For instance, in May 2024, over 60% of the U.S. dogs and 55% of cats are obese, driving a 19% rise in therapeutic weight management diet sales.
The U.S. pet therapeutic diet market was valued at USD 1.40 billion in 2024 and is expected to reach USD 2.48 billion by 2032, growing at a CAGR of 7.40% over 2025-2032.
The US has the largest pet health therapeutic diet market share as pet owners are led by veterinary practices through nutritional assessments and scientifically-based, responsible nutritional therapy options. And with some 93% of cat owners leaning on vets for advice, the veterinary profession is the biggest force driving demand for therapeutic and preventive diets. Its preventative attitudes to obesity, chronic disease, and changing dietary requirements have successfully propelled high penetration of therapeutic diets, with the U.S. being the world’s origin market for such products.
For instance, in February 2025, in the U.S., 68% of chronic disease consultations led to therapeutic diet recommendations by veterinarians, highlighting their pivotal role in clinical nutrition guidance.
Market Dynamics:
Drivers:
- Nutrition Is a Major Driving the Pet Therapeutic Diet Market Growth
The pet therapeutic diet market share is driven by a need for nutrition that supports preventive pet healthcare, which can help manage chronic ailments, improve immunity, and promote long life. Personalized diets can address obesity, allergies, and digestion-related problems, as demands for personalized care rise. As veterinarians recommend proactive nutrition, the pet therapeutic diet market grows as pet owners add health-oriented, preventive dietary choices to their sales.
For instance, in April 2025, APPA reported that 72% of U.S. pet owners choose therapeutic diets for chronic conditions, driving a significant rise in preventive nutrition-focused pet food sales.
Restraints:
- Competition Over Homemade Diets is a Significant Restraint on the Pet Therapeutic Diet Market Growth
Homemade diets also pose competition for the pet therapeutic diet market growth as many of the pet owners consider homemade diets to be healthier and natural. Nevertheless, homemade diets are still primarily preferred although they are nutrient-deficient and potentially contaminated because of myths, mistrust of commercial foods, and wish for ingredient control. This impression limits the acceptance of science-based therapeutic diets targeting chronic disease, and the expansion of the market for these therapeutic diets, although known to improve health.
For instance, in February 2025, ACVN reported 28% of U.S. pet owners use homemade diets, with 60% nutritionally inadequate, hindering pet therapeutic diet market adoption.
Segmentation Analysis:
By Product
Dry Food is the dominant and fastest growing segment in the global pet therapeutic diet market, with a 65.26% market share in 2024, owing to its long shelf life, easy storage, and thrifty convenience to pet owners. It facilitates accurate nutrient formulation for the treatment of diseases including obesity, diabetes, and renal disease. Furthermore, dry kibble promotes dental care and is well received by veterinarians. Its lower cost of production and extensive retail and hospital distribution all helped to establish its dominance in the space of pet therapeutic diets.
By Animal Type
In 2024, the dogs dominated the pet therapeutic diet industry with a 62.80% market share, owing to the large number of dogs globally and increasing knowledge about canine health problems, including obesity, joint disease, and kidney disease. Therapeutic diets for the management of these disorders have become the diet of choice for many pet owners. Veterinary endorsement and the emotional bond between owners and dogs are other factors that bring demand for preventive care, positioning dogs as the leading consumer segment in the therapeutic pet nutrition market.
The cats segment is the fastest growing aspect of the pet therapeutic diet market analysis, with A CAGR of 8.01% over the forecast period, driven by the growing number of cat owners, higher prevalence of cat-specific diseases, including renal disease, urinary tract diseases, and later on, more knowledge on customized nutrition for cats. Pet parents are searching for specific diets to help manage chronic conditions, and more veterinarians recommend therapeutic foods, driving adoption in the growing feline healthcare category.
By Indication
Obesity Care held a dominant pet therapeutic diet market share of 20.89% of the pet therapeutic diet market industry in 2024. Driven by the increasing percentage of overweight pets, or dogs, especially. Demand for weight management diets is driven by rising awareness of health conditions associated with obesity, including joint pain, diabetes, and heart disease. Veterinarians commonly recommend weight management therapeutic foods, which drive the long-term health of pets and drive the segment growth significantly.
Renal Care is emerging as the fastest growing segment in the pet therapeutic diet industry with the highest CAGR of 8.16%, propelled by increased cases of chronic kidney disease in older pets. The demand for renal-specific nutrition is mainly fuelled by early and accurate diagnosis and growing veterinary assistance. Such targeted dietary interventions support longevity and management of symptoms, playing a major role in the pet therapeutic diet market growth as owners seek effective, long-term nutritional solutions for chronic conditions, including kidney disease.
By Distribution Channel
Veterinary hospitals & clinics are the largest segment of the pet therapeutic diet industry, offering greater use of veterinarian-prescribed nutrition for disease treatment. Pet parents believe in the clinical efficacy of condition-specific diets and are more compliant. Nutritional therapy through this channel is precise, fortifying its leading position and strongly contributing towards the overall distribution of the market share.
The E-commerce segment is witnessing the highest growth in the pet therapeutic diet market, fuelled by the growing digital adoption, ease of home delivery, and wider product assortment. Online purchasing of therapeutic diets is becoming more popular with pet owners for repeat purchases. Subscription services and the availability of vet-approved diets at competitive prices add to this growth, expanding reach and access to the pet therapeutics diet market in a meaningful way.
Regional Analysis:
In 2024, the North American region holds the largest market share of the pet therapeutic diet industry and dominates the market with a 41.60% market share, owing to the large pet population, education regarding pet health, and a solid veterinary infrastructure. High demand is also fuelled by the region’s mature pet care industry and increasing prevalence of long-term conditions including obesity and kidney problems in pets, combined with the ready availability of therapeutic diets. Furthermore, premiumization of pet food, increased e-commerce penetration, and the advent of proactive pet parenting also drive market growth. Strong presence of the key players also serves to augment the dominance of North America in the pet therapeutic diet market.
Europe is the second-largest market for the global pet therapeutic diet market as owners become more conscious of their pets’ health, are visiting the vet more, and looking for specialized food. Countries including Germany, France, and the UK lead the way in terms of pet adoption and spending. Rising adoption of preventive pet healthcare, high-end pet food products, and government initiatives for animal welfare change the dynamics of the region in the pet therapeutic diet market
Asia-Pacific emerges as the fastest-growing region with the highest CAGR of 8.28%, driven by growing pet ownership, higher disposable incomes, and rising awareness on companion animal health. Urbanisation in countries including China, India, Japan, and South Korea has contributed to a rise in nuclear families rearing pets, particularly dogs and cats. Demand is also rising for therapeutic diets that address obesity, renal problems, and allergies, as more pet owners are informed about prevention. Moreover, broadening veterinary base, emergence of pet e-commerce platforms, and increased penetration of western pet care trends are fuelling the growth of the market. Adoption of government policies for animal welfare, and rising popularity of premium international brands, are the major drivers of the pet therapeutic diet market in the Asia-Pacific.
The Middle East & Africa has the least pet therapeutic diet market share and is attributed to less pet ownership, poor knowledge of pet nutrition, and the nascent status of the veterinary healthcare industry. Economic limitations and cultural constraints limit the use of specialized pets’ diets. Strict regulations for veterinarians, coupled with the shortage of drugs and less awareness about animal health, are some of the restraining factors for the growth of the market in this region.
The pet therapeutic diet market in Latin America is estimated to have a moderate share due to urbanization, increasing penetration of pets, and awareness of pet health. Demand for specialized diets is growing in countries including Brazil and Mexico, where veterinary care is on the rise. However, progress is hindered by disparities in income, erratic product availability, and much weaker penetration by premium therapeutic brands than in North America and Western Europe. Yet the region has been demonstrating consistent potential.
Key Players
Pet therapeutic diet Companies, including Hill’s Pet Nutrition, Royal Canin, Purina Pro Plan Veterinary Diets, Blue Buffalo, Farmina Vet Life, Rayne Clinical Nutrition, Virbac, Dechra, IAMS Veterinary Formula, VetDiet, Veterinary Diet Solutions, Balance IT, JustFoodForDogs, Nom Nom, SquarePet, Petcurean, Trovet, Animonda, Vetnova, Affinity Petcare, and other players.
Recent Developments
-
In February 2025, Hill’s launched Prescription Diet Derm Complete in February 2025, targeting chronic skin issues in pets. It uses bioactives and Omega-3s to reduce allergic flare-ups and support skin health.
-
In January 2025, Blue Buffalo reformulated GI Gastrointestinal Support dog food with enhanced digestibility, natural ingredients, and antioxidant fibers to better manage digestive disorders and promote gut health.
-
In April 2025, Virbac expanded its Veterinary HPM diet range with a new Obesity Management formula for dogs, aiming to improve weight loss outcomes through high-protein, low-carb nutrition.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 4.20 billion |
| Market Size by 2032 | USD 7.47 billion |
| CAGR | CAGR of 7.48% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Wet Food, Dry Food, Others) • By Animal Type (Dogs, Cats, Others) • By Indication (Renal Care, Obesity Care, Diabetic Care, Dental Care, Gastrointestinal Care, Recovery Care, Joint Care, Others) • By Distribution Channel(E-commerce, Veterinary hospitals & clinics, Retail Pharmacies, Others)" |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Hill’s Pet Nutrition, Royal Canin, Purina Pro Plan Veterinary Diets, Blue Buffalo, Farmina Vet Life, Rayne Clinical Nutrition, Virbac, Dechra, IAMS Veterinary Formula, VetDiet, Veterinary Diet Solutions, Balance IT, JustFoodForDogs, Nom Nom, SquarePet, Petcurean, Trovet, Animonda, Vetnova, Affinity Petcare and other players. |
Table of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Product
2.3.2 Market Size By Animal Type
2.3.3 Market Size By Indication
2.3.4 Market Size By Distribution Channel
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Disease Prevalence and Therapeutic Diet Demand (2020–2032)
4.1.1 Global and regional prevalence of chronic conditions in pets (obesity, kidney disease, allergies, etc.)
4.1.2 Growth rate comparison: therapeutic diets vs standard pet food
4.1.3 Most commonly prescribed therapeutic diet categories by condition (renal, gastrointestinal, metabolic, etc.)
4.2 Pet Demographics and Ownership Trends (2024)
4.2.1 Age-wise and species-wise (dog, cat, others) distribution of pets on therapeutic diets
4.2.2 Urban vs rural adoption of therapeutic diets
4.2.3 Influence of pet insurance coverage on therapeutic diet adoption
4.3 Distribution Channels and Retail Infrastructure (2020–2024)
4.3.1 Market share by sales channel: veterinary clinics, e-commerce, pet retail chains
4.3.2 Number of veterinary clinics offering therapeutic diets by region
4.3.3 In-store vs online availability and SKU variation of therapeutic diet products
4.4 Pricing and Reimbursement Trends (2024)
4.4.1 Average price of therapeutic diet products vs regular pet food
4.4.2 Reimbursement trends under pet insurance for therapeutic diets
4.4.3 Impact of inflation and raw material costs on therapeutic diet pricing
4.5 Consumer Awareness and Behavior Insights (2024)
4.5.1 Pet owner awareness of diet-linked disease management
4.5.2 Factors influencing purchase: vet recommendation, brand loyalty, ingredients
4.5.3 Trends in online reviews, subscription models, and personalized diet services
5. Pet Therapeutic Diet Market Segmental Analysis & Forecast, By Product, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Wet Food
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Dry Food
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 Others
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
6. Pet Therapeutic Diet Market Segmental Analysis & Forecast, By Animal Type, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Dogs
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Cats
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Others
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
7. Pet Therapeutic Diet Market Segmental Analysis & Forecast, By Indication, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Renal Care
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Obesity Care
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Diabetic Care
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
7.5 Dental Care
7.5.1 Key Trends
7.5.2 Market Size & Forecast, 2021 – 2032
7.6 Gastrointestinal Care
7.6.1 Key Trends
7.6.2 Market Size & Forecast, 2021 – 2032
7.7 Recovery Care
7.7.1 Key Trends
7.7.2 Market Size & Forecast, 2021 – 2032
7.8 Joint Care
7.8.1 Key Trends
7.8.2 Market Size & Forecast, 2021 – 2032
7.9 Others
7.9.1 Key Trends
7.9.2 Market Size & Forecast, 2021 – 2032
8. Pet Therapeutic Diet Market Segmental Analysis & Forecast, By Distribution Channel, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 E-commerce
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Veterinary hospitals & clinics
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Retail Pharmacies
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
8.5 Others
8.5.1 Key Trends
8.5.2 Market Size & Forecast, 2021 – 2032
9. Pet Therapeutic Diet Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.2.3 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.2.4 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.2.5 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.2.6 Pet Therapeutic Diet Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.2.6.1.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.2.6.1.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.2.6.1.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.2.6.2.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.2.6.2.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.2.6.2.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.3.3 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.3.4 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.3.5 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6 Pet Therapeutic Diet Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.3.6.1.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.3.6.1.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.3.6.1.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.3.6.2.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.3.6.2.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.3.6.2.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.3.6.3.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.3.6.3.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.3.6.3.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.3.6.4.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.3.6.4.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.3.6.4.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.3.6.5.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.3.6.5.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.3.6.5.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.3.6.6.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.3.6.6.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.3.6.6.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.3.6.7.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.3.6.7.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.3.6.7.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.3.6.8.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.3.6.8.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.3.6.8.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.4.3 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.4.4 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.4.5 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6 Pet Therapeutic Diet Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.4.6.1.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.4.6.1.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.4.6.1.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.4.6.2.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.4.6.2.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.4.6.2.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.4.6.3.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.4.6.3.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.4.6.3.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.4.6.4.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.4.6.4.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.4.6.4.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.4.6.5.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.4.6.5.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.4.6.5.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.4.6.6.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.4.6.6.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.4.6.6.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.4.6.7.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.4.6.7.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.4.6.7.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.5.3 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.5.4 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.5.5 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.5.6 Pet Therapeutic Diet Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.5.6.1.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.5.6.1.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.5.6.1.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.5.6.2.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.5.6.2.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.5.6.2.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.5.6.3.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.5.6.3.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.5.6.3.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.5.6.4.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.5.6.4.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.5.6.4.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.5.6.5.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.5.6.5.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.5.6.5.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.6.3 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.6.4 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.6.5 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6.6 Pet Therapeutic Diet Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.6.6.1.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.6.6.1.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.6.6.1.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.6.6.2.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.6.6.2.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.6.6.2.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.6.6.3.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.6.6.3.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.6.6.3.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.6.6.4.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.6.6.4.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.6.6.4.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.6.6.5.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.6.6.5.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.6.6.5.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Pet Therapeutic Diet Market Size & Forecast, By Product, 2021 – 2032
9.6.6.6.2 Pet Therapeutic Diet Market Size & Forecast, By Animal Type, 2021 – 2032
9.6.6.6.3 Pet Therapeutic Diet Market Size & Forecast, By Indication , 2021 – 2032
9.6.6.6.4 Pet Therapeutic Diet Market Size & Forecast, By Distribution Channel, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 Hill’s Pet Nutrition
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Royal Canin
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 Purina Pro Plan Veterinary Diets
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 Blue Buffalo
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Farmina Vet Life
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Rayne Clinical Nutrition
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 Virbac
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 Dechra
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 IAMS Veterinary Formula
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 VetDiet
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Veterinary Diet Solutions
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 Balance IT
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 JustFoodForDogs
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 Nom Nom
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 SquarePet
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 Petcurean
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Trovet
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 Animonda
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 Vetnova
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Affinity Petcare
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List of Tables
14.2 List of Figure
Key Segments:
By Product
-
Wet Food
-
Dry Food
-
Others
By Animal Type
-
Dogs
-
Cats
-
Others
By Indication
-
Renal Care
-
Obesity Care
-
Diabetic Care
-
Dental Care
-
Gastrointestinal Care
-
Recovery Care
-
Joint Care
-
Others
By Distribution Channel
-
E-commerce
-
Veterinary hospitals & clinics
-
Retail Pharmacies
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
